Linshom Receives SBIR Phase II Contract Award from the United States Air Force for Its Dual Purpose Respiratory Device
Linshom announced today receipt of a phase II SBIR contract award with the United States Air Force (USAF) to fund ongoing development and deployment of the Linshom Predictive Continuous Respiratory Monitoring (LPCRM) System. The $748K contract follows successful completion of a SBIR phase 1 award... - April 27, 2021
Linshom Announces European Patent Coverage for the Linshom Continuous Respiratory Monitor
Linshom announced today receipt of patents in five European countries including Germany, France, Spain, Italy and Great Britain. This adds to and expands the current Linshom patent portfolio held in the United States, Canada, Japan, Mexico and China. The lack of a simple, portable and inexpensive... - January 28, 2021
Linshom Announces FDA Clearance of the Linshom Respiratory Monitoring Device (LRMD)
Linshom announced today U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s first product, a small, non-invasive respiratory monitor that addresses the growing need for continuous respiratory monitoring for patients susceptible to respiratory depression and... - February 06, 2020